Emotional Resolution Therapy for Anxiety
(CalmER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether Emotional Resolution (EmRes) therapy can reduce anxiety levels in healthcare workers more effectively than mindfulness-based gratitude exercises. Participants will attend six one-hour sessions over nine weeks, with follow-up assessments to evaluate treatment effectiveness. It targets hospital healthcare workers who experience anxiety and are not currently taking anxiety medication.
As an unphased trial, this study provides healthcare workers the chance to explore innovative therapies for managing anxiety.
Will I have to stop taking my current medications?
If you are currently taking anxiety medications like Beta Blockers or Benzodiazepines, you cannot participate in this trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Emotional Resolution (EmRes) therapy helps people manage emotions like anxiety and depression by focusing on bodily sensations. This method, known as viscerosomatic quieting, connects the body and mind to address emotional issues. Although specific data on the safety of EmRes is limited, its non-invasive, medication-free nature suggests it is generally safe.
In contrast, mindfulness practices, which this study compares, have a strong safety record. Studies have found that mindfulness-based methods can reduce anxiety and depression without serious side effects. These practices involve concentrating on the present moment to enhance mental well-being.
Both treatments in this study use natural, non-drug approaches to help manage anxiety with minimal risks. However, discussing any concerns with healthcare professionals before joining a trial is always important.12345Why are researchers excited about this trial?
Unlike standard anxiety treatments that often rely on medication or traditional talk therapy, Emotional Resolution Therapy (EmRes) offers a unique approach by focusing on resolving emotional responses at their root. This method aims to help individuals process and integrate unresolved emotional experiences, potentially leading to more lasting changes. Researchers are excited about EmRes because it offers a non-pharmacological option that can be conducted remotely, making it more accessible and convenient for participants. The therapy's structured approach, spread across six sessions via Zoom, also emphasizes personal empowerment and practical emotional management skills.
What evidence suggests that this trial's treatments could be effective for reducing anxiety?
Research has shown that Emotional Resolution (EmRes) therapy, one of the treatments under study in this trial, can help reduce anxiety. Studies have found that EmRes enables people to understand the root of their emotions, leading to fewer anxiety symptoms. Participants using EmRes have reported feeling clearer about their emotions and experiencing less anxiety. In one case study, a person no longer met the criteria for generalized anxiety disorder after four months of EmRes therapy. EmRes works through a process called viscero-somatic quieting, which helps the body handle past trauma and emotional issues.12456
Are You a Good Fit for This Trial?
This trial is for healthcare workers over 18 who are fluent in English and currently work in a hospital. They should have a Generalized Anxiety Disorder (GAD) score of more than 5, indicating some level of anxiety, and must be able to give written consent to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Emotional Resolution therapy or mindfulness-based gratitude intervention over six one-hour sessions via Zoom
Follow-up
Participants are monitored for changes in anxiety, stress, and burnout levels after treatment
What Are the Treatments Tested in This Trial?
Interventions
- EmRes
- Mindfulness
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor